Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans
- PMID: 1630876
- DOI: 10.1007/BF01962691
Direct measurement of probenecid and its glucuronide conjugate by means of high pressure liquid chromatography in plasma and urine of humans
Abstract
Probenecid with its phase-I metabolites, and phase-II glucuronide conjugate can be analysed by a gradient high pressure liquid chromatographic method. Probenecid glucuronide in plasma with pH 7.4 is not stable and declines to 10% of the original value within 6 h (t1/2 approximately 1 h). Probenecid glucuronide is stable in urine with pH 5.0, moderately unstable at pH 6.0 (t1/2 approximately 10 h), and unstable at pH 8.0 (t1/2 approximately 0.5 h). Probenecid glucuronide is stable in water and 0.01 mol/l phosphoric acid in the autosampler of the high pressure liquid chromatograph. The decrease in concentration in water is 5.5% during 9 h and 0% in diluted acid. Probenecid glucuronide and the phase-I metabolites were not detectable in plasma. The main compound in fresh urine is the phase-II conjugate probenecid glucuronide (62% of a 500 mg dose); the phase-I metabolites are present and only a trace of probenecid is present. The percentage of the dose of the phase-I metabolites varies between 5 and 10, while hardly any probenecid is excreted unchanged (0.33%).
Similar articles
-
Direct-gradient high-performance liquid chromatographic analysis and preliminary pharmacokinetics of flumequine and flumequine acyl glucuronide in humans: effect of probenecid.J Chromatogr. 1992 Aug 7;579(1):131-41. doi: 10.1016/0378-4347(92)80371-v. J Chromatogr. 1992. PMID: 1447340
-
The simultaneous analysis of clofibric acid and probenecid and the direct analysis of clofibric acid glucuronide by high-performance liquid chromatography.J Chromatogr. 1981 Apr 10;223(1):147-54. doi: 10.1016/s0378-4347(00)80077-8. J Chromatogr. 1981. PMID: 7251756
-
Rapid high-performance liquid chromatographic assay for the simultaneous determination of probenecid and its glucuronide in urine. Irreversible binding of probenecid to serum albumin.J Pharm Biomed Anal. 1991;9(1):65-73. doi: 10.1016/0731-7085(91)80239-6. J Pharm Biomed Anal. 1991. PMID: 2043725
-
Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis. Preliminary pharmacokinetics and effect of probenecid.J Chromatogr. 1993 Jul 2;616(2):271-82. doi: 10.1016/0378-4347(93)80395-k. J Chromatogr. 1993. PMID: 8376508
-
Direct gradient reversed-phase high-performance liquid chromatographic determination of salicylic acid, with the corresponding glycine and glucuronide conjugates in human plasma and urine.J Chromatogr. 1994 Feb 11;652(2):161-70. doi: 10.1016/0378-4347(93)e0381-y. J Chromatogr. 1994. PMID: 8006100
Cited by
-
Probenecid inhibits the renal clearance and renal glucuronidation of nalidixic acid. A pilot experiment.Pharm World Sci. 1993 Aug 20;15(4):165-70. doi: 10.1007/BF01880560. Pharm World Sci. 1993. PMID: 8220301
-
Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide.Br J Clin Pharmacol. 1995 Jun;39(6):692-5. Br J Clin Pharmacol. 1995. PMID: 7654491 Free PMC article. Clinical Trial.
-
Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.Pharm Weekbl Sci. 1992 Oct 16;14(5):325-31. doi: 10.1007/BF01977622. Pharm Weekbl Sci. 1992. PMID: 1437517
-
Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment.Pharm World Sci. 1994 Feb 18;16(1):22-6. doi: 10.1007/BF01870935. Pharm World Sci. 1994. PMID: 8156046
-
Interindividual variation in the capacity-limited renal glucuronidation of probenecid by humans.Pharm World Sci. 1993 Oct 15;15(5):197-202. doi: 10.1007/BF01880626. Pharm World Sci. 1993. PMID: 8257956